These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 16188573

  • 1. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S, Dharmalingam S, Erickson-Nesmith S, Ren S, Zhu F, Ma GM, Zhao R, Fenton JW, Ofosu FA, Velthuis HT, van Mierlo G, Shen GX.
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [Abstract] [Full Text] [Related]

  • 2. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S, Comlekci A, Akinci B, Demir T, Yuksel F, Ozcan MA, Bayraktar F, Yesil S.
    Med Princ Pract; 2009 Nov; 18(4):266-71. PubMed ID: 19494532
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 4. The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients.
    Vukovich T, Proidl S, Knöbl P, Teufelsbauer H, Schnack C, Schernthaner G.
    Thromb Haemost; 1992 Sep 07; 68(3):253-6. PubMed ID: 1440487
    [Abstract] [Full Text] [Related]

  • 5. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics.
    Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG.
    Thromb Haemost; 1999 Mar 07; 81(3):367-72. PubMed ID: 10102462
    [Abstract] [Full Text] [Related]

  • 6. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK, Stavroulakis G, Papadopoulos DP, Krespi P, Hatzizacharias A, Zilidis A, Tsoukala C, Votteas VE.
    Drugs Exp Clin Res; 2004 Mar 07; 30(3):125-32. PubMed ID: 15366789
    [Abstract] [Full Text] [Related]

  • 7. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A, Federici MO, Mourvaki E, Ferolla P, Piroddi M, Stabile A, Timi A, Celleno R, Benedetti MM.
    Thromb Haemost; 2007 Sep 07; 98(3):635-41. PubMed ID: 17849053
    [Abstract] [Full Text] [Related]

  • 8. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P, Kotuličová D, Staško J, Kubisz P.
    Blood Coagul Fibrinolysis; 2011 Sep 07; 22(6):493-8. PubMed ID: 21519232
    [Abstract] [Full Text] [Related]

  • 9. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 07; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y, Okumura KI, Yoshida N, Tayama K, Takemura Y, Inukai T.
    Exp Clin Endocrinol Diabetes; 2004 Apr 07; 112(4):175-80. PubMed ID: 15127320
    [Abstract] [Full Text] [Related]

  • 11. Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients.
    Rigla M, Wägner AM, Borrell M, Mateo J, Foncuberta J, de Leiva A, Ordóñez-Llanos J, Pérez A.
    Metabolism; 2006 Nov 07; 55(11):1437-42. PubMed ID: 17046544
    [Abstract] [Full Text] [Related]

  • 12. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS, Aslam M, Naveed AK, Razi MS.
    Saudi Med J; 2006 Feb 07; 27(2):174-80. PubMed ID: 16501671
    [Abstract] [Full Text] [Related]

  • 13. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C, Hacihasanoğlu A, Celik S, Ovali E, Ersöz HO, Ukinç K, Deger O, Telatar M.
    Med Princ Pract; 2005 Feb 07; 14(1):22-30. PubMed ID: 15608477
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes.
    Morimitsu LK, Fusaro AS, Sanchez VH, Hagemann CC, Bertini AM, Dib SA.
    Diabetes Res Clin Pract; 2007 Dec 07; 78(3):340-8. PubMed ID: 17544539
    [Abstract] [Full Text] [Related]

  • 15. Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.
    Rigla M, Mateo J, Fontcuberta J, Souto JC, de Leiva A, Pérez A.
    Thromb Haemost; 2000 Aug 07; 84(2):223-7. PubMed ID: 10959693
    [Abstract] [Full Text] [Related]

  • 16. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW, Catto AJ, Carter AM, Grant PJ.
    Diabet Med; 1998 Nov 07; 15(11):953-7. PubMed ID: 9827850
    [Abstract] [Full Text] [Related]

  • 17. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 18. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J, Hodinár A, Kvasnicka J, Hilgertová J.
    Diabet Med; 1996 Sep 01; 13(9):800-5. PubMed ID: 8891455
    [Abstract] [Full Text] [Related]

  • 19. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.
    Exp Clin Endocrinol Diabetes; 2008 Nov 01; 116(10):619-24. PubMed ID: 18484067
    [Abstract] [Full Text] [Related]

  • 20. Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients.
    Ying S, Sun YM, Liu XM, An CY, Gao YY.
    Biochem Biophys Res Commun; 2007 Nov 16; 363(2):395-8. PubMed ID: 17870053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.